iRhythm Technologies: Study Published in JAMA Cardiology Finds Zio by iRhythm Proactively Identifies AFib, Increases Detection Tenfold
iRhythm Technologies advises the transatlantic clinical trial found that Zio by iRhythm, an ambulatory cardiac monitoring solution, led to a tenfold increase in the detection of atrial fibrillation (AF) versus patients receiving standard clinical care.